Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Parathyroid Neoplasms 3Hyperparathyroidism, Primary 3Hyperparathyroidism 3Neoplasm Metastasis 2Prostatic Neoplasms 1Osteoporosis 1Hyperparathyroidism, Secondary 1Hypercalcemia 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Cinacalcet 3fluorocholine 1evocalcet 1Tablets 1Standard of Care 1Sodium Chloride 1Parathyroidectomy 1Denosumab 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hyperparathyroidism, Primary × Cinacalcet × Clear all
NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed
46 enrolled 49 charts
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT01460030 2017-03-03

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed
Head & Neck

Hypercalcemia, Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT00037518 2013-05-08

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Amgen

Phase 4 Completed
46 enrolled
Head & Neck

Hyperparathyroidism, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡